A gene that controls inflammation could pave the way for more precise disease diagnostics and personalised treatments for kidney disease.
For the first time, we have the tools to greatly reduce kidney disease. How can we make sure they get to those who need them?
Researchers will examine new treatments to improve outcomes for people with advanced kidney disease and those who have experienced an ischaemic stroke.
The former Executive Director of The George Institute for Global Health, Professor Vlado Perkovic, starts as UNSW’s new Dean of Medicine today.
The research contributions of UNSW PhD student Dr Adeniyi Borire have been recognised by the American Association of Neuromuscular and Electrodiagnostic Medicine.
A drug that lowers blood sugar levels for people with type 2 diabetes has been revealed to also significantly reduce the risk of both cardiovascular and kidney disease.